Semaglutide can promote the expression of β-klotho (KLB) to mediate ferroptosis inhibition under DKD through the activation of the AMPK signaling pathway, subsequently reducing inflammation and fibrosis as well as alleviation of renal tubular injury [148]. This evidence concerns the gene KLB and diabetic kidney disease.